Blackhawk Capital Partners Llc. Ampio Pharmaceuticals, Inc. Transaction History

Blackhawk Capital Partners Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.16 - $0.47 $2,480 - $7,285	-15,500 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$1.56 - $1.98 $24,180 - $30,690	15,500 New	15,500 $26,000
Q1 2021 May 11, 2021	SELL	$1.36 - $2.49 $21,080 - $38,595	-15,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.61 - $1.17 $9,455 - $18,135	15,500 New	15,500 $10,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.